-
Police Investigate Bedford Parent for Hallway Incident After Playoff Loss
-
Joe Biden Makes Surprise Appearance at Trinity College Dublin for Hunter's Medal
-
Regal Cinemas Launches 4DX Screenings for 'Heated Rivalry' Amid Immersive Theater Trend
-
Bank of Korea Governor Shin Hyun-song Appointed First Asian Chair of BIS Payment Committee
-
Texas Car Buyers: Legal Remedies When a Defective Vehicle Isn't a 'Lemon'
-
Northern California Jewish Sports Hall of Fame Announces 2026 Inductees
-
Phil Spencer on Housing Market Fairness: How Buyers and Sellers Navigate Falling Prices
-
Readers Debate GTA 6 Spin-offs, Server Strain, and Warner Bros. Decline in Games Inbox
-
An Investigational Drug to Tackle Measles Outbreaks
-
Retired Army Officer Earns Two Degrees While Navigating Family Health Challenges
-
Ondas Receives Purchase Order for Next-Generation Tactical Attack Drones, Aims to Leverage Planned ARAN Defense Acquisition to Manufacture Thousands of Systems
-
First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
-
Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
-
ACCESS Newswire Reports Third Quarter 2026 Results
-
T4 Robotics Appoints Paul Hughes as Co-CEO and Announces Expansion into Unmanned Maritime Systems
-
ClearSign Receives Order for "M1" Series Burner from Tulsa Heaters Midstream (THM)
-
Kalm with Kava and Pū'iwa Farms Hawai'i Bring Fresh Frozen Hawaiian Kava to Market
-
Innovative Menopause Medicine from JASTLabs Advances Patent Protection Internationally
-
SMX Advances Development of its Scientific Intelligence, an AI-Powered Platform Intended to Create a Comprehensive Codex for Chemical Agents, Additives and Supplements
-
Jerash Holdings Reports Fiscal 2027 Second Quarter Financial Results
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
SNZweig Forms AEC Industry Advisory Council
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
Moderna to Present at Upcoming Conference in November 2026
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
The Arthritis Foundation Welcomes Zoetis as Two-Year National Presenting Sponsor of Jingle Bell Run and Walk to Cure Arthritis
The partnership joins forces to support arthritis patients and their beloved pets
The partnership joins forces to support arthritis patients and their beloved pets
The Arthritis Foundation welcomes Zoetis, maker of innovative therapies for osteoarthritis pain in pets, as the two-year National Presenting Sponsor of the Jingle Bell Run and Walk to Cure Arthritis. Zoetis' commitment to supporting arthritis patients, whether they have two legs or four, is invaluable as the Arthritis Foundation works to raise awareness of its tools and resources for people living with the serious impacts of arthritis-the leading cause of disability in the US.
"Zoetis' support as Presenting Sponsor of Jingle Bell Run through 2025 and Walk to Cure Arthritis through 2026 will help us fund the next generation of treatment research and provide life-changing science, resources, advocacy and community connections to people living with arthritis," said Steven Taylor, President and CEO of the Arthritis Foundation. "Studies show that spending time with a beloved dog, cat or other pet has real physical and mental health benefits for people with arthritis. By advancing care for animals, Zoetis stands by people with arthritis and their pets."
As part of this partnership, Zoetis will activate at select Jingle Bell Run events in 2024 and 2025 and Walk to Cure Arthritis events in 2025 and 2026, providing educational resources and tools to pet owners on how to recognize the signs and symptoms of osteoarthritis pain in their dogs and cats. This December, Zoetis will be present at dog-friendly Jingle Bell Runs in Arizona, Arkansas, California, Colorado, Florida, Georgia, Kansas, Kentucky, New Jersey, New York, Ohio, Pennsylvania, Oklahoma, Texas, Washington State and Washington D.C. Zoetis will be offering pets and pet owners an arthritis friendly leash (while supplies last), treats, water and pet care information at their exhibit booth during these events.
"Sadly, nearly 40% of dogs and cats,[1][2] respectively, will suffer from osteoarthritis in their lifetime. Everyday activities can be painful for them and even worse, we may miss the subtle signs of this pain, which may indicate an early onset of the disease and negatively impact their wellbeing, as well as the special bond we share with them. That's why maintaining a strong relationship with your veterinarian is such an important part of controlling your pet's OA pain," said Ester Banque, Executive Vice President and President, U.S. Operations, Zoetis. "We are eager to partner with Arthritis Foundation due to our shared dedication to advancing care and improving quality of life for those living with arthritis - whether those in need have two legs or four. We look forward to engaging with the many pet lovers in the arthritis community."
Arthritis Foundation events aim to help people with arthritis better manage their disease and connect with others in the arthritis community. Jingle Bell Run and Walk to Cure Arthritis participants, donors and fundraisers not only show support for loved ones with arthritis, but also fuel the Foundation's scientific research, educational resources and opportunities to connect.
For more information, visit arthritis.org.
About the Arthritis Foundation
The Arthritis Foundation is fighting for all people who live with arthritis. As Champions of Yes, the Arthritis Foundation has a mission to turn the obstacles arthritis causes into opportunities. The Arthritis Foundation not only champions life-changing solutions and medical advancements, but it also provides ways for people to connect, break down barriers in health care, and join the fight to conquer arthritis - uniting hearts, minds, and resources to change the future of arthritis.
About Zoetis
As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide - from veterinarians and pet owners to livestock farmers and ranchers. The company's leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetispetcare.com
CONTACT:
Julie Thomas
[email protected]
212.980.9064
[1] IHS Markit. (2021) Canine and Feline Pain Market 2021: Animal Health Market Analysis; Wright A, et al. Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests. J Small Anim Pract, 2022. http://doi.org/10.1111/jsap.13500.
[2] Enomoto, M, et al., Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. Vet Rec, 2019.
SOURCE: The Arthritis Foundation
H.Romero--AT